Kapila Viges: Executive Director
Chicago, IL – The MPN Research Foundation has announced Kapila Viges as Executive Director. Through research, advocacy, and education, the MPN Research Foundation brings together patients, researchers, and clinicians around the common goal of realizing new treatments and, ultimately, a cure for polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN). Viges brings a strong background in supporting cancer research, biopharma interactions, and the development of creative partnerships to accelerate new therapy development.
Her public, academic, and industry sector leadership experience including management and strategy consulting in biomedical industry, biomedical startup incubation and seed investing of translational research, and public-private-partnerships in economic development will propel the Foundation to a new level of research funding and innovation.
The mission of the MPN Research Foundation is to stimulate original research in pursuit of new treatments – and eventually a cure – for the blood cancers polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN). MPNRF is approaching its 20th anniversary of funding research, connecting patients to the latest discoveries, sharing educational resources and building hope.